Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy

Ran Salomon, Rony Dahan

Weizmann Institute of Science

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science